Universidade de Lisboa Repositório da Universidade de Lisboa

Repositório da Universidade de Lisboa >
Faculdade de Medicina (FM) >
Instituto de Medicina Preventiva (FM-IMP) >
FM-IMP-Artigos em Revistas Internacionais >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10451/4642

Título: EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
Autor: Peters, M. J. L.
Symmons, D. P. M.
McCarey, D.
Dijkmans, B. A. C.
Nicola, P.
Kvien, T. K.
McInnes, I. B.
Haentzschel, H.
Gonzalez-Gay, M. A.
Provan, S.
Semb, A.
Sidiropoulos, P.
Kitas, G.
Smulders, Y. M.
Soubrier, M.
Szekanecz, Z.
Sattar, N.
Nurmohamed, M. T.
Palavras-chave: Artrite reumatóide
Risco cardiovascular
Artrite inflamatória
Issue Date: 2010
Editora: BMJ Publishing Group
Citação: Ann Rheum Dis 2010;69:325–331
Resumo: Objectives: To develop evidence-based EULAR recommendations for cardiovascular (CV) risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Methods: A multidisciplinary expert committee was convened as a task force of the EULAR Standing Committee for Clinical Affairs (ESCCA), comprising 18 members including rheumatologists, cardiologists, internists and epidemiologists, representing nine European countries. Problem areas and related keywords for systematic literature research were identified. A systematic literature research was performed using MedLine, Embase and the Cochrane library through to May 2008. Based on this literature review and in accordance with the EULAR’s ‘‘standardised operating procedures’’, the multidisciplinary steering committee formulated evidencebased and expert opinion-based recommendations for CV risk screening and management in patients with inflammatory arthritis. Results: Annual CV risk assessment using national guidelines is recommended for all patients with RA and should be considered for all patients with AS and PsA. Any CV risk factors identified should be managed according to local guidelines. If no local guidelines are available, CV risk management should be carried out according to the SCORE function. In addition to appropriate CV risk management, aggressive suppression of the inflammatory process is recommended to further lower the CV risk. Conclusions: Ten recommendations were made for CV risk management in patients with RA, AS and PsA. The strength of the recommendations differed between RA on the one hand, and AS and PsA, on the other, as evidence for an increased CV risk is most compelling for RA.
Descrição: Additional tables are published online only at http:// ard.bmj.com/content/vol69/ issue2
Arbitragem científica: yes
URI: http://hdl.handle.net/10451/4642
ISSN: 0003-4967
Appears in Collections:FM-IMP-Artigos em Revistas Internacionais

Files in This Item:

File Description SizeFormat
Rheumatoid arthritis.pdfArtigo635,67 kBAdobe PDFView/Open

Please give feedback about this item
FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Logotipo do DeGóis 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.


  © Universidade de Lisboa / SIBUL
Alameda da Universidade | Cidade Universitária | 1649-004 Lisboa | Portugal
Tel. +351 217967624 | Fax +351 217933624 | repositorio@reitoria.ul.pt - Feedback - Statistics
Promotores do RCAAP   Financiadores do RCAAP

Fundação para a Ciência e a Tecnologia Universidade do Minho   Governo Português Ministério da Educação e Ciência PO Sociedade do Conhecimento (POSC) Portal oficial da União Europeia